Pain Relief Brands

Prescription COX-2 inhibitor anti-inflammatory medication for treating arthritis pain, originally developed by G.D. Searle & Company and now marketed by Pfizer.

Pfizer's brand name for pregabalin, a neuropathic pain and fibromyalgia treatment approved by the FDA in 2004, now owned by Viatris following the 2020 Upjohn spinoff and Mylan merger.

American brand of ibuprofen pain relief medication owned by Kenvue, the consumer health spinoff from Johnson & Johnson, which is being acquired by Kimberly-Clark in a $40 billion deal announced in November 2025.

Ibuprofen-based analgesic and anti-inflammatory brand owned by Reckitt. The leading OTC pain relief brand across the UK, Australia, and several European and Asian markets.

Brand of pain relief medication containing paracetamol (acetaminophen) used for treating mild to moderate pain and fever, manufactured and marketed globally by Haleon.

American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023.

Over-the-counter anti-inflammatory pain relief brand containing diclofenac, owned by Haleon plc (LSE/NYSE: HLN) since its July 2022 spinoff from the GSK and Pfizer consumer health joint venture, with Voltaren growing mid-single digit in full-year 2025 supported by new format patches and Voltadexibu launches.